In stroke survivors, does the clinical effectiveness of 6 months treatment with fluoxetine depend upon its effects on synaptic plasticity in the brain? Can a drug used for depression help stroke recovery by changing connections between brain cells?
Can a drug commonly used for gout improve recovery and prevention of further stroke for stroke survivors?
On 12 February 2015, at the International Stroke Conference (ISC 2015) in Nashville, USA, the findings of a Stroke Association-funded study were presented, called CADISS (Cervical Artery Dissection In Stroke Study).
Funded by the Wellcome Trust, researchers at Newcastle University have shown that, in monkeys, it is possible to restore hand and arm movement lost through brain damage.
Thousands of lives a year could be changed thanks to a pilot research study by Imperial College which involves injecting a patient's stem cells into their brain.
Published online first in the journal Neurology, a new study suggests that people with AF who have an ICH due to their medication have similar outcomes whether they're on a NOAC or a vitamin K antagonist drug.
Thrombolysis, where drugs are injected into the blood to break up a blood clot, is one of the main treatments used to treat people who are having a stroke caused by a clot. Currently a drug called alteplase is used in thrombolysis. But the researchers think that another drug, called tenecteplase, may be more effective than alteplase. This study will investigate if this is the case.
Early Supported Discharge (ESD) is the discharge of a stroke patient from hospital to their own home, co-ordinated by a team of therapists, nurses and a doctor. A number of ESD services have been set up across England. Do these services offer the same benefits to patients as those identified in clinical trials?
This project aims to develop and test a repetitive functional task practice (RFTP) therapy programme. Research physiotherapists will develop the programme in conjunction with stroke unit staff and patients.
Today, the Association of Medical Research Charities (AMRC) launched a new spotlight report highlighting the positive difference medical research charities are making for mental health patients across the UK.